In both patients, no tissue growth factor was used to pharma¬ cologically assist in the closure of the macular hole. Although these two patients represent a limited experi¬ ence, patients with proliferative dia¬ betic retinopathy and a macular hole may have a poorer visual prognosis after hole closure than patients with idiopathic macular hole.